Asian Spectator

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

Magazine

Apakah AI telah meretas sistem operasi peradaban manusia? Peringatan dari Yuval Noah Harari

TechSolution/ShutterstockBuku Sapiens: A Brief History of Humankind dan Homo Deus: A Brief History of Tomorrow telah melatih kita untuk mengharapkan ide-ide revolusioner dari sejarawan ternama, Yuval ...

Transplantasi rambut makin marak, ketahui risikonya lebih dahulu

Seorang laki-laki memperlihatkan kulit kepalanya yang penuh lubang tusukan dan keropeng akibat transplantasi rambut.Andranik Hakobyan / ShutterstockKerontokan rambut bisa memengaruhi fase tertentu dal...

Mengapa memilih bertahan? Riset temukan bias kognitif di balik kekerasan dalam pacaran

Ilustrasi kekerasan dalam pacaran.Tinnakorn jorruang/ShutterstockTrigger warning: Artikel ini ini mengandung konten kekerasan eksplisit yang dapat memicu perubahan kondisi emosi dan mental pembaca.Hub...



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion